[1]
“Evaluation of Cardiovascular Risk of Selective and Nonselective Cyclooxygenase Inhibitors (COX-Is) in Arthritic Patients: A Comparative Matched Case Control Study”, J. Sci. Res., vol. 6, no. 2, pp. 329–338, Apr. 2014, doi: 10.3329/jsr.v6i2.17039.